Cardiovascular risk review
The cardiovascular picture has genuinely changed, and a good testosterone specialist will explain both halves of it. TRAVERSE, a randomized placebo-controlled trial of 5,246 men aged 45 to 80 with existing or high cardiovascular risk, found testosterone gel noninferior to placebo for cardiovascular death and nonfatal heart attack. On that evidence the FDA issued class-wide labeling changes on February 28, 2025, which removed the cardiovascular boxed warning.
The same decision required a new warning about increased blood pressure across testosterone products, based on completed ambulatory blood pressure monitoring studies. The "limitation of use" language for age-related hypogonadism stayed. TRAVERSE also recorded more pulmonary embolism in the testosterone arm than in placebo, along with more atrial fibrillation, at 91 versus 63 cases.
So the honest summary is that major adverse cardiac events did not increase in a high-risk population studied for a mean of 22 months, while clotting and blood pressure remain live concerns. Your history of thromboembolism and any cardiovascular event in the past three to six months change the calculation. The AUA suggests waiting three to six months after a cardiovascular event before starting. Untreated sleep apnea belongs in this discussion too, since it worsens with the same red cell changes testosterone drives.
Hematocrit monitoring
Testosterone stimulates red blood cell production, and this is the side effect you're most likely to encounter. Short-acting intramuscular testosterone cypionate and enanthate carry the highest rates, with erythrocytosis approaching 40% in some series, while extended-release testosterone undecanoate produced a hematocrit above 50% in only 7% of 347 patients across 3,022 injections.
Thicker blood moves worse. In the Tromsø study, men in the top quintile for hematocrit had a 1.5-fold relative risk of venous thromboembolism after adjustment for age and body mass index, which rose to 2.4-fold for unprovoked events.
The monitoring schedule is specific. Measure hemoglobin and hematocrit at baseline and again at three to six months. If baseline hematocrit exceeds 50%, the guideline says to withhold treatment until the cause of the elevation is identified. Above 54% during therapy, stop until it falls to a safe level and restart at a reduced dose. European guidance treats 54% as a contraindication while American guidance uses 50% as a threshold for concern, so ask which your TRT doctor follows and what they'll do when a number crosses it. A clinic whose answer is "we'd probably send you for a phlebotomy and keep the dose" is managing a symptom.
Check consent and follow-up
Informed consent feels balanced enough that you're briefly unsure whether to proceed. That means hearing what testosterone reliably improves and where the evidence is thin. Anawalt describes the Testosterone Trials this way: giving symptomatic older men with low levels testosterone increased sex drive and improved erectile function about half as effectively as Viagra. Mood and vitality improved in men who were genuinely low. Men whose levels sat at the low end of normal saw no improvement. No study found a cognitive benefit.
Counseling gaps are common in the fast-prescribing model. Half the platforms in the JAMA study stated a treatment target of 1,000 ng/dL or higher and never mentioned fertility risk, and 83.3% said nothing about polycythemia. Compare that to the guideline target, which is the mid-normal range.
Before you leave the first appointment, you walk out with specifics:
-
Your dose, your formulation, and how to administer it correctly.
-
When your next labs are scheduled, and which markers they'll include.
-
The date of your symptom reassessment and the follow-up interval, which depends on formulation. Testosterone levels are checked two to eight hours after gel application, or before the next injection for testosterone undecanoate.
-
Who to contact within 24 hours if something feels wrong, and how.
Costs belong in writing too. Ask what happens to the monthly fee if you and your TRT doctor decide to stop, and whether lab work is billed separately.
Spot TRT clinic red flags
Most warning signs come down to one pattern: the treatment decision was made before you walked in. A TRT clinic that offers testosterone on a single lab value, or on symptoms alone, has skipped the requirement that made the diagnosis meaningful. In the JAMA study, six of seven platforms had no total testosterone threshold at all for starting treatment, and only one asked about recent cardiovascular events or future fertility.
Watch for these:
-
Guaranteed results, or promises about energy and body composition stated as certainties.
-
One protocol for every patient, with dose and formulation chosen before your labs return.
-
Pressure to enroll in a membership during your first conversation.
-
Fertility questions brushed aside, or a target level quoted above the normal range.
-
No named TRT doctor supervising your care, and no way to reach one.
-
No monitoring schedule in writing, or lab intervals longer than six months in your first year.
-
A phone number that reaches only sales, and no route to clinical help between visits.
Joshua Halpern, one of the Northwestern Medicine authors of that study, put the tradeoff plainly: online platforms have real potential to expand access, "however, until these services are providing therapies based on established guidelines, it's important that patients and providers are educated on the potential pitfalls." Access without standards isn't a bargain.
Choose your TRT doctor
Bring the same short list to every consultation and compare what you hear. Will you repeat my morning test before diagnosing me? What else could be causing this? What's my baseline hematocrit and PSA, and at what number do you act? How does treatment affect my fertility, and what are my options if that matters? When are my next labs, and who reviews them?
The TRT doctor who answers all five without hesitation is the one paying attention to your medicine.
TNT Wellness has provided physician-supervised hormone therapy since 1993, with baseline lab work and ongoing monitoring through virtual or in-person visits at our Charlotte practice. If you want a careful evaluation before anything is prescribed, schedule a consultation with a TRT doctor on our team.